Cargando…

Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses

Reston viruses are the only Ebolaviruses that are not pathogenic in humans. We analyzed 196 Ebolavirus genomes and identified specificity determining positions (SDPs) in all nine Ebolavirus proteins that distinguish Reston viruses from the four human pathogenic Ebolaviruses. A subset of these SDPs w...

Descripción completa

Detalles Bibliográficos
Autores principales: Pappalardo, Morena, Juliá, Miguel, Howard, Mark J., Rossman, Jeremy S., Michaelis, Martin, Wass, Mark N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806318/
https://www.ncbi.nlm.nih.gov/pubmed/27009368
http://dx.doi.org/10.1038/srep23743
_version_ 1782423218353602560
author Pappalardo, Morena
Juliá, Miguel
Howard, Mark J.
Rossman, Jeremy S.
Michaelis, Martin
Wass, Mark N.
author_facet Pappalardo, Morena
Juliá, Miguel
Howard, Mark J.
Rossman, Jeremy S.
Michaelis, Martin
Wass, Mark N.
author_sort Pappalardo, Morena
collection PubMed
description Reston viruses are the only Ebolaviruses that are not pathogenic in humans. We analyzed 196 Ebolavirus genomes and identified specificity determining positions (SDPs) in all nine Ebolavirus proteins that distinguish Reston viruses from the four human pathogenic Ebolaviruses. A subset of these SDPs will explain the differences in human pathogenicity between Reston and the other four ebolavirus species. Structural analysis was performed to identify those SDPs that are likely to have a functional effect. This analysis revealed novel functional insights in particular for Ebolavirus proteins VP40 and VP24. The VP40 SDP P85T interferes with VP40 function by altering octamer formation. The VP40 SDP Q245P affects the structure and hydrophobic core of the protein and consequently protein function. Three VP24 SDPs (T131S, M136L, Q139R) are likely to impair VP24 binding to human karyopherin alpha5 (KPNA5) and therefore inhibition of interferon signaling. Since VP24 is critical for Ebolavirus adaptation to novel hosts, and only a few SDPs distinguish Reston virus VP24 from VP24 of other Ebolaviruses, human pathogenic Reston viruses may emerge. This is of concern since Reston viruses circulate in domestic pigs and can infect humans, possibly via airborne transmission.
format Online
Article
Text
id pubmed-4806318
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48063182016-03-24 Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses Pappalardo, Morena Juliá, Miguel Howard, Mark J. Rossman, Jeremy S. Michaelis, Martin Wass, Mark N. Sci Rep Article Reston viruses are the only Ebolaviruses that are not pathogenic in humans. We analyzed 196 Ebolavirus genomes and identified specificity determining positions (SDPs) in all nine Ebolavirus proteins that distinguish Reston viruses from the four human pathogenic Ebolaviruses. A subset of these SDPs will explain the differences in human pathogenicity between Reston and the other four ebolavirus species. Structural analysis was performed to identify those SDPs that are likely to have a functional effect. This analysis revealed novel functional insights in particular for Ebolavirus proteins VP40 and VP24. The VP40 SDP P85T interferes with VP40 function by altering octamer formation. The VP40 SDP Q245P affects the structure and hydrophobic core of the protein and consequently protein function. Three VP24 SDPs (T131S, M136L, Q139R) are likely to impair VP24 binding to human karyopherin alpha5 (KPNA5) and therefore inhibition of interferon signaling. Since VP24 is critical for Ebolavirus adaptation to novel hosts, and only a few SDPs distinguish Reston virus VP24 from VP24 of other Ebolaviruses, human pathogenic Reston viruses may emerge. This is of concern since Reston viruses circulate in domestic pigs and can infect humans, possibly via airborne transmission. Nature Publishing Group 2016-03-24 /pmc/articles/PMC4806318/ /pubmed/27009368 http://dx.doi.org/10.1038/srep23743 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Pappalardo, Morena
Juliá, Miguel
Howard, Mark J.
Rossman, Jeremy S.
Michaelis, Martin
Wass, Mark N.
Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses
title Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses
title_full Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses
title_fullStr Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses
title_full_unstemmed Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses
title_short Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses
title_sort conserved differences in protein sequence determine the human pathogenicity of ebolaviruses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806318/
https://www.ncbi.nlm.nih.gov/pubmed/27009368
http://dx.doi.org/10.1038/srep23743
work_keys_str_mv AT pappalardomorena conserveddifferencesinproteinsequencedeterminethehumanpathogenicityofebolaviruses
AT juliamiguel conserveddifferencesinproteinsequencedeterminethehumanpathogenicityofebolaviruses
AT howardmarkj conserveddifferencesinproteinsequencedeterminethehumanpathogenicityofebolaviruses
AT rossmanjeremys conserveddifferencesinproteinsequencedeterminethehumanpathogenicityofebolaviruses
AT michaelismartin conserveddifferencesinproteinsequencedeterminethehumanpathogenicityofebolaviruses
AT wassmarkn conserveddifferencesinproteinsequencedeterminethehumanpathogenicityofebolaviruses